Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-24-044904
Filing Date
2024-11-12
Accepted
2024-11-12 18:26:16
Documents
1
Period of Report
2024-10-28

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1557
  Complete submission text file 0001493152-24-044904.txt   3115
Mailing Address 20271 GOLDENROD LANE GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE GERMANTOWN MD 20876 (480) 659-6404
Orgenesis Inc. (Issuer) CIK: 0001460602 (see all company filings)

EIN.: 980583166 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 20271 GOLDENROD LN. GERMANTOWN MD 20876
Business Address
PELAVIN ADAM (Reporting) CIK: 0002043500 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38416 | Film No.: 241450472